Effects of carboxy-PTIO on systemic hemodynamics, liver energetics, and concentration of liver metabolites during endotoxic shock in rabbits: A 31P and 1H magnetic resonance spectroscopic study

Critical Care Medicine

Volumn 25, Issue 6, 1997, Pages 1019-1029

  Kaneda, Koh ^a   Yoshioka, Yoshichika ^b   Makita, Koshi ^a   Toyooka, Hidenori ^c   Amaha, Keisuke ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

ATP; Carboxy PTIO; Endotoxic shock; Hepatocellular dysfunction; Intracellular pH; Lipopolysaccharide; Liver; Magnetic resonance; Nitric oxide; Rabbit

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CELL PH; CONTROLLED STUDY; HEMODYNAMIC MONITORING; LIVER METABOLISM; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; SEPTIC SHOCK;

ACIDOSIS; ADENOSINE TRIPHOSPHATE; ANIMALS; BENZOATES; BLOOD PRESSURE; FREE RADICAL SCAVENGERS; HYDROGEN; HYPOTENSION; IMIDAZOLES; LIPOPOLYSACCHARIDES; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; NITRIC OXIDE; PHOSPHATES; PHOSPHORUS RADIOISOTOPES; RABBITS; SHOCK, SEPTIC;

EID: 0030902503     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199706000-00020     Document Type: Article

References (58)

1. 31P]NMR assessment of early hepatocellular dysfunction during endotoxemia. J Surg Res 1992; 52:505-509
2. Hirata K, Kaneko A, Ogawa K, et al: Effect of endotoxin on rat liver: Analysis of acid phosphatase isozymes in liver of normal and endotoxin-treated rats. Lab Invest 1980; 43:165-171
3. Nolan JP: Endotoxin, reticuloendothelial function, and liver injury. Hepatology 1981; 1:458-465
4. Abello PA, Buchman TG, Bulkey GB: Shock and multiple organ failure. In: Free Radicals in Diagnostic Medicine. Armstrong D (Ed). New York, Plenum Press, 1994, pp 253-268
5. Bone RC: The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-469
6. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142
7. Kilbourn RG, Griffith OW: Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 1992; 84:827-831
8. +. Biochem Biophys Res Commun 1993; 196:1208-1213
9. Thiemermann C: The role of the L-arginine: Nitric oxide pathway in circulatory shock. Adv Pharmacol 1994; 28:45-79
10. Szabó C: Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995; 3:2-32
11. G-monomethyl-L-arginine. J Cardiovasc Pharmacol 1992; 20: S132-S134
12. Ma TT, Ischiropoulos H, Brass CA: Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology 1995; 108:463-469
13. Harbrecht BG, Billiar TR, Stadler J, et al: Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol 1992; 52:390-394
14. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 1990; 48:565-569
15. Nishida J, Mccuskey RS, Mcdonnell D, et al: Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 1994; 267:G1135-G1141
16. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57
17. Pastor CM, Payen DM: Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 1994; 2:196-202
18. Maeda H, Akaike T, Yoshida M, et al: Multiple functions of nitric oxide in pathophysiology and microbiology: Analysis by a new nitric oxide scavenger. J Leukoc Biol 1994; 56:588-592
19. Yoshida M, Akaike T, Wada Y, et al: Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun 1994; 202:923-930
20. Kobayashi T, Robinson MK, Jacobs DO, et al: Glutathione depletion alters hepatocellular high-energy phosphate metabolism. J Surg Res 1993; 54:189-195
21. 1 and nicardipine in rabbits: An in vivo magnetic resonance spectroscopic study. Anesth Analg 1993; 77: 606-612
22. Marquardt DW: An algorithm for least-squares estimation nonlinear parameters. Journal of the Society for Industrial and Applied Mathematics 1963; 11:431-441
23. 31P-NMR spectroscopy of rat liver treated with halocarbons. Biochim Biophys Acta 1989; 993:92-99
24. Folch J, Lees M, Stanley GHS: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226:497-509
25. 31P-NMR of extracted phospholipid. J Lipid Res 1988; 29:679-689
26. 1H-NMR assignments. Biochim Biophys Acta 1986; 882:154-167
27. 1H-NMR. Anal Biochem 1989; 178:67-76
28. 31P-NMR. J Lipid Res 1986; 27: 386-392
29. Petrovich DR, Finkelstein S, Waring AJ, et al: Liver ischemia increases the molecular order of microsomal membranes by increasing the cholesterol-to-phospholipid ratio. J Biol Chem 1984; 259:13217-13223
30. Yokoyama T, Okamoto R, Ozawa K, et al: Hepatic energy status in hypotension of different aetiologies in dogs. Clin Sci (Colch) 1991; 81:627-633
31. Keaney JF, Puyana JC Jr, Francis S, et al: Methylene blue reverses endotoxin-induced hypotension. Circ Res 1994; 74:1121-1125
32. Szabó C, Mitchell JA, Thiemermann C, et al: Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993; 108:786-792
33. Hotchkiss RS, Song S-K, Neil JJ, et al: Sepsis does not impair tricarboxylic acid cycle in the heart. Am J Physiol 1991; 260:C50-C57
34. Jacobs DO, Kobayashi T, Imagire J, et al: Sepsis alters skeletal muscle energetics and membrane function. Surgery 1991; 110:318-326
35. 31P-NMR spectroscopy. Am J Physiol 1989; 257:C1055-C1061
36. Hotchkiss RS, Karl IE: Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992; 267:1503-1510
37. Geller DA, Freewick PD, Billiar TR, et al: Differential induction of nitric oxide synthase in hopatocytes during endotoxemia and the acute-phase response. Arch Surg 1994; 129:165-171
38. Weiner MW: NMR spectroscopy for clinical medicine: Animal models and clinical examples. Physiological NMR spectroscopy: From isolated cells to man. Ann N Y Acad Sci 1987; 508:287-299
39. van Lambalgen AA, van Kraats AA, Mulder MF, et al: High-energy phosphates in heart, liver, kidney, and skeletal muscle of endotoxemic rats. Am J Physiol 1994; 266:H1581-H1587
40. Brady AJB, Poole-Wilson PA, Harding SE, et al: Nitric oxide production within cardiac myocyte reduces their contractility in endotoxemia. Am J Physiol 1992; 263:H1963-H1966
41. Finkel MS, Oddis CV, Jacob TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-398
42. Zhang H, Rogiers P, Preiser JC, et al: Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med 1995; 23:1711-1721
43. Stadler J, Ronald DC, Billiar TR, et al: Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch Surg 1991; 126:186-191
44. Geng YJ, Hansson GK, Holme E: Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992; 71:1268-1276
45. Horton RA, Ceppi ED, Knowles RG, et al: Inhibition of hepatic gluconeogenesis by nitric oxide: A comparison with endotoxic shock. Biochem J 1994; 299:735-739
46. Vadas P, Hay JB: Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock. Can J Physiol Pharmacol 1983; 61:561-566
47. Liu MS, Ghosh S, Yang Y: Change in membrane lipid fluidity induced by phospholipase A activation: A mechanism of endotoxic shock. Life Sci 1983; 33:1995-2002
48. Chien KR, Abram J, Serroni A, et al: Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury. J Biol Chem 1978; 253:4809-4817
49. Mittal MK, Gupta TK, Groszmann RJ, et al: Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994; 267:G416-G422
50. Amrani M, O'Shea J, Allen NL, et al: Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol (Lond) 1992; 456:681-687
51. 2 delivery in septic dogs. Am J Physiol 1995; 268:H2017-H2023
52. Fukatsu K, Saito H, Muto T, et al: Detrimental effects of a nitric oxide synthase inhibitor (N-ω-nitro-L-arginine-methyl-ester) in a murine sepsis model. Arch Surg 1995; 130:410-414
53. Pastor C, Teisseire B, Vicaut E, et al: Effects of L-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 1994; 22:465-469
54. Wu CC, Chen SJ, Szabó C, et al: Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 1995; 114: 1666-1672
55. Szabó C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91:12472-12476
56. Redl H, Bahrami S, Traber DL, et al: Clinical detection of LPS and animal models of endotoxemia. Immunobiology 1993; 187:330-345
57. Fink MP, Heard SO: Laboratory models of sepsis and septic shock. J Surg Res 1990; 49:186-196
58. Aranow JS, Wang H, Fink MP, et al: Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock. Crit Care Med 1996; 24:807-814